Elsevier

Atherosclerosis

Volume 130, Issues 1–2, April 1997, Pages 215-221
Atherosclerosis

Altered mononuclear phagocyte differentiation associated with genetic defects of the lysosomal acid lipase

https://doi.org/10.1016/S0021-9150(97)06065-6Get rights and content

Abstract

Multiparameter flow cytometry reveals a complex heterogeneity of mononuclear phagocyte differentiation within the peripheral blood compartment. In this study, the relation of abnormal cellular lipid metabolism to the phenotype of peripheral blood mononuclear phagocytes, which finally may be related to atherogenesis, was analyzed using recently characterized autosomal recessive defects of lysosomal acid lipase (LAL) expression as model system. The reduction of LAL activity in nine heterozygote, disease free carriers of mutations from two cholesteryl ester storage disease (CESD) pedigrees and the family of a patient with Wolman disease was associated with an increased fraction of monocytes which expressed CD56 (N-CAM) (4.1±2.7% of monocytes, compared to 2.2±0.5% in ten controls, P<0.05), an antigen characteristic of immature myeloid cells, suggesting an increased turnover of monocytes. Furthermore, a trend was observed towards an enhanced blood pool of more mature mononuclear phagocytes which show decreased expression of the 55 kD lipopolysaccharide receptor (CD14) together with either expression of the Fc-γ-receptor III (CD16) or a high expression of CD33. A similar phenotype of peripheral mononuclear phagocytes was observed in the two CESD patients analyzed. In conclusion, our data suggest that these monogenetic defects of lysosomal lipoprotein metabolism are associated with complex alterations of mononuclear phagocyte differentiation and extravasation.

Introduction

The early pathogenesis of atherosclerosis is characterized already by an increased adhesion of monocytes to the injured endothelium followed by extravasation into the vessel wall [1]. Within the wall, the unregulated cellular lipid accumulation by monocytes leads to foam cell formation and the development of fatty streaks [2]. Furthermore, activated macrophages secrete cytokines and modify lipoproteins at least in part by oxidation. There is increasing evidence that the phenotype of peripheral blood monocytes may be affected dependent on disturbances of cellular lipid or lipoprotein metabolism. Thus, there appears to be an enhanced monocyte progenitor proliferation in animal models of hypercholesterolemia [3]. Functional abnormalities such as impaired monocyte signal transduction have been observed in hypercholesterolemic patients [4]. Furthermore, enhanced antigen presentation has been reported upon pre-incubation of monocytes in cholesterol-rich media [5].

Using multiparameter flow cytometry our group has recently been able to demonstrate an altered phenotype of the highly heterogeneous peripheral blood monocytes in patients with hypercholesterolemia [6]. In comparison to the predominant population of monocytes, small subpopulations of peripheral blood mononuclear phagocytes are characterized by a decreased expression of the 55 kD LPS-receptor (CD14) together with the expression of either the Fc-γ-receptor-III (CD16) correlating to phagocytically active cells or a high expression of surface molecules related to antigen presentation such as HLA-DR and CD40 correlating to cells which are assumed to be the blood precursors of dendritic cells 6, 7, 8, 9, 10. Furthermore, a subset of cells expresses the CD56 (N-CAM) antigen which is also found in less differentiated forms of acute myeloid leukemia suggesting that these cells represent a more immature fraction of monocytes. In our study, patients with hypercholesterolemia had an increased fraction of CD14dimCD16+ monocytes which both correlated with the E4/E4 phenotype of the apolipoprotein E and low plasma levels of HDL cholesterol.

Both the apolipoprotein E phenotype and the level of cellular apolipoprotein E expression are tightly linked to cellular lipoprotein uptake and metabolism. Thus the expression of the more positively charged apolipoprotein E4 is related to higher plasma cholesterol levels through enhanced hepatic internalization of remnants from triglyceride-rich lipoproteins [11]. Furthermore, the uptake of triglyceride-rich lipoprotein particles and intracellular cholesteryl ester hydrolysis are increased by exogenous apolipoprotein E [12]or dependent on cellular apolipoprotein E secretion [13]. Monogenetic defects of lysosomal acid lipase/acid cholesteryl ester hydrolase (LAL/ACEH; EC 3.1.1.13) expression represent a further well characterized determinant of cellular lipoprotein uptake 14, 15.

In this study individuals with a reduced LAL expression served as a further model for the study of the relation of an abnormal cellular lipid metabolism to the phenotype of mononuclear phagocytes. These individuals were identified among the family members of patients with the autosomal recessive infantile-onset Wolman disease (WD) and late-onset cholesteryl ester storage disease (CESD) which both have been attributed to reduced levels of LAL [15]. Compared to controls, WD patients tend to have <1% LAL activity while CESD patients have enzymatic activities <10%. Recently, the genomic organization of the gene for LAL and different mutations leading to CESD and WD have been identified 16, 17, 18, 19, 20, 21. Genotype-phenotype relations in CESD and WD are, however, still poorly understood.

Section snippets

Patients and controls

Individuals with a partially defective LAL expression were identified among the family members of patients with WD and CESD. The distribution of the individual alleles and mutations of pedigrees A (CESD) [22], B (CESD) [19], and C (WD) [20]are shown in Fig. 1. The study was approved by the Hospital Ethics Committee and informed consent was obtained from all probands. The nine carriers of LAL mutations had a mean age of 28.6 years. With the exception of a 5 and 7 year old child and a 59 year old

Phenotypic and genetic characterization of defective LAL expression in CESD and WD patients and their family members

The goal of this study was the analysis of the relation of abnormal cellular lipid metabolism to the phenotype of mononuclear phagocytes based on well defined defects of LAL expression in members of the families of CESD and WD patients 19, 20, 22. The distribution of individual alleles and mutations of two pedigrees with CESD and a pedigree with WD which were available for the characterization of peripheral blood mononuclear phagocyte subpopulations are shown in Fig. 1.

Two individuals from

Discussion

The characterization of phenotypic alterations of mononuclear phagocytes in relation to defects of LAL expression, which represent well characterized monogenetically determined disorders of cellular lipoprotein metabolism, represents a new approach towards the characterization of potential cellular mechanisms of atherogenesis. Within the wall, phenotypic alterations of mononuclear phagocytes are characteristically associated to lesion progression 1, 2. Increasingly, however, an altered function

References (35)

  • Ross R. Cell biology of atherosclerosis. Ann Rev Physiol...
  • Van der Wal AC, Das PK, Tigges AJ, Becker AE. Macrophage differentiation in atherosclerosis. An in situ...
  • Averill LE, Meagher RC, Gerrity RG. Enhanced monocyte progenitor cell proliferation in bone marrow of hyperlipemic...
  • Stragliotto E, Camera M, Postiglione A, Sirtori M, Di Minno G, Tremoli E. Functionally abnormal monocytes in...
  • Hughes DA, Townsend PJ, Haslam PL. Enhancement of the antigen-presenting function of monocytes by cholesterol: possible...
  • Rothe G, Gabriel H, Kovacs E, Klucken J, Stöhr J, Kindermann W, Schmitz G. Peripheral blood mononuclear phagocyte...
  • Passlick B, Flieger D, Ziegler-Heitbrock HWL. Identification and characterization of a novel monocyte subpopulation in...
  • Ziegler-Heitbrock HWL, Fingerle G, Ströbel M, Schraut W, Stelter F, Schütt C, Passlick B, Pforte A. The novel subset of...
  • Thomas R, Davis LS, Lipsky PE. Isolation and characterization of human peripheral blood dendritic cells. J Immunol...
  • Thomas R, Lipsky PE. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and...
  • Dallongeville J, Lussier-Cacan S, Davignon J. Modulation of plasma triglyceride levels by apo E phenotype: a...
  • Schwiegelshohn B, Presley JF, Gorecki M, Vogel T, Carpentier YA, Maxfield FR, Deckelbaum RJ. Effects of apoprotein E on...
  • Choi SY, Komaromy MC, Chen J, Fong LG, Cooper AD. Acceleration of uptake of LDL but not chylomicron remnants by cells...
  • Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem...
  • Schmitz G, Assmann G. Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease. In: Scriver CR,...
  • Anderson RA, Sando GN. Cloning and expression of cDNA encoding human lysosomal acid lipase/cholesteryl ester hydrolase....
  • Aslanidis C, Klima H, Lackner KJ, Schmitz G. Genomic organization of the human lysosomal acid lipase gene (LIPA)....
  • Cited by (14)

    • A novel myeloid-like NK cell progenitor in human umbilical cord blood

      2003, Blood
      Citation Excerpt :

      Because it has been recently reported in mice that T-cell and B-cell progenitors are generated from a common myelolymphoid progenitor,24 we could possibly suggest that NK cells also develop from a common myelolymphoid progenitor, as it is well established that they arise from a common T/NK progenitor.9 Moreover, the existence of (1) a common bipotent progenitor for NK and dendritic cells,31which have functional similarity to monocytes/macrophages, (2) myeloid leukemias expressing CD56,32-34 and (3) CD14+CD56+ cells in normal human PB (considered a subpopulation of monocytes)35-36 constitute further evidence of the existence of a common myelolymphoid progenitor in humans. Whether UCB/CD14+ cells represent such a progenitor, having the capacity to differentiate into other myeloid or lymphoid lineages as well, remains to be investigated.

    • Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes

      2001, Blood
      Citation Excerpt :

      However, the influence of Lp(a) on blood monocytes is poorly investigated. There is increasing evidence that blood monocyte function may be changed by dyslipidemia.14 More mature monocytes are described in patients with xanthomatosis18 and an increased expression of CCR2 was demonstrated in monocytes from donors with elevated LDL-C.31

    View all citing articles on Scopus
    View full text